How do you ensure smooth and efficient progression throughout your product’s life cycle?

New technology could lead to development of novel "xenoprotein" drugs against infectious diseases

XenoGesis and BioAscent Discovery Limited have announced a collaboration to offer an enhanced range of integrated drug discovery services

The authors of a new report illustrate how a magnetic nanoparticle assembly approach is used to increase throughput dramatically while reducing costs

The team determined the first crystal structure for a neuropeptide Y receptor, deciphering the thousands of carbon, oxygen, nitrogen, and other atoms involved with it and how they bind to one another

A multi-institutional project to understand one of the major targets of human drug design has produced new insights into how structural communication works in a cell component called a G protein-coupled receptor

Early lab-based tests of a recently developed drug were successful in targeting resistant breast cancers and indicated minimal side effects

First-to-market Edit-R CRISPRa arrayed crRNA libraries enable native gene overexpression for high-throughput gain-of-function screening

Consortium will develop a QSP Immuno-oncology Simulator to test combination cancer therapies and different dose regimens and biomarkers in computer-generated, virtual patients

The Quasi Vivo® System is available with three different culture chambers (QV500, QV600, and QV900) to support a wide range of applications